Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Brennscheidt

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Biology|July 1, 1990
Molecular organization of the human Raf-1 promoter regionT W Beck, U Brennscheidt, G Sithanandam, et al.
Leukemia|October 1, 1994
Mechanisms of p53 alteration in acute leukemiasA Schottelius, U Brennscheidt, W D Ludwig, et al.
Leukemia|May 1, 1994
Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemiaU Brennscheidt, D Eick, R Kunzmann, et al.
Genomics|March 1, 1994
The complete sequence and promoter activity of the human A-raf-1 gene (ARAF1)J E Lee, T W Beck, U Brennscheidt, et al.
Leukemia|November 1, 1990
Gamma-interferon interrupts growth stimulation in chronic myelogenous leukemia established by endogenous granulocyte colony-stimulating factorD Riedel, A Lindemann, J Otto, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1994
Raf-1 is a necessary component of the mitogenic response of the human megakaryoblastic leukemia cell line MO7 to human stem cell factor, granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 9U Brennscheidt, D Riedel, W Kölch, et al.
Oncology|July 1, 1997
Dacarbazine and interferon alpha for stage IV malignant melanomaI Tamm, H Grimme, E Bergen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 22, 2002
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patientsM P Glauser, U Brennscheidt, O Cornely, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1995
Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumorsR Mertelsmann, A Lindemann, T Boehm, et al.
Oncogene|April 1, 1989
Loss of heterozygosity at the c-raf locus in small cell lung carcinomaG Sithanandam, M Dean, U Brennscheidt, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Biology|July 1, 1990
Molecular organization of the human Raf-1 promoter regionT W Beck, U Brennscheidt, G Sithanandam, et al.
Leukemia|October 1, 1994
Mechanisms of p53 alteration in acute leukemiasA Schottelius, U Brennscheidt, W D Ludwig, et al.
Leukemia|May 1, 1994
Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemiaU Brennscheidt, D Eick, R Kunzmann, et al.
Genomics|March 1, 1994
The complete sequence and promoter activity of the human A-raf-1 gene (ARAF1)J E Lee, T W Beck, U Brennscheidt, et al.
Leukemia|November 1, 1990
Gamma-interferon interrupts growth stimulation in chronic myelogenous leukemia established by endogenous granulocyte colony-stimulating factorD Riedel, A Lindemann, J Otto, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1994
Raf-1 is a necessary component of the mitogenic response of the human megakaryoblastic leukemia cell line MO7 to human stem cell factor, granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 9U Brennscheidt, D Riedel, W Kölch, et al.
Oncology|July 1, 1997
Dacarbazine and interferon alpha for stage IV malignant melanomaI Tamm, H Grimme, E Bergen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 22, 2002
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patientsM P Glauser, U Brennscheidt, O Cornely, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1995
Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumorsR Mertelsmann, A Lindemann, T Boehm, et al.
Oncogene|April 1, 1989
Loss of heterozygosity at the c-raf locus in small cell lung carcinomaG Sithanandam, M Dean, U Brennscheidt, et al.
Pageof 3